3D Cellular Architecture Modulates Tyrosine Kinase Activity, Thereby Switching CD95-Mediated Apoptosis to Survival by Gülcüler Balta, Gülce S. et al.
Title3D Cellular Architecture Modulates Tyrosine Kinase Activity,Thereby Switching CD95-Mediated Apoptosis to Survival
Author(s)
Gülcüler Balta, Gülce S.; Monzel, Cornelia; Kleber, Susanne;
Beaudouin, Joel; Balta, Emre; Kaindl, Thomas; Chen, Si; Gao,
Liang; Thiemann, Meinolf; Wirtz, Christian R.; Samstag,
Yvonne; Tanaka, Motomu; Martin-Villalba, Ana











3D Cellular Architecture Modulates Tyrosine Kinase




d Specific intermolecular spacing of CD95Ligand induces
efficient CD95 clustering
d CD95 clustering triggers apoptotic and survival signaling
d CD95 signals survival in the presence of cell-cell contact
d Cell-cell contact increases levels of phosphotyrosinated
proteins including CD95
Authors
G€ulce S. G€ulc€uler Balta, Cornelia Monzel,
Susanne Kleber, ..., Yvonne Samstag,






G€ulc€uler Balta et al. show that CD95
receptor activation is determined through
the presentation of its ligand at a certain
intermolecular distance. The type of
signaling triggered by CD95 is, however,
decided by the cellular environment.
CD95 triggers survival in cancer cells in
contact with other cells and death in
isolated ones.
G€ulc€uler Balta et al., 2019, Cell Reports 29, 2295–2306




3D Cellular Architecture Modulates
Tyrosine Kinase Activity, Thereby Switching
CD95-Mediated Apoptosis to Survival
G€ulce S. G€ulc€uler Balta,1,2 Cornelia Monzel,3,11 Susanne Kleber,1 Joel Beaudouin,5,6,12 Emre Balta,7 Thomas Kaindl,3
Si Chen,1 Liang Gao,1,13 Meinolf Thiemann,8 Christian R. Wirtz,9 Yvonne Samstag,7 Motomu Tanaka,3,10,*
and Ana Martin-Villalba1,14,*
1Department of Molecular Neurobiology, German Cancer Research Center (DFKZ), Im Neuenheimer Feld 581, 69120 Heidelberg, Germany
2Faculty of Biosciences, Heidelberg University, 69120 Heidelberg, Germany
3Physical Chemistry of Biosystems, Institute of Physical Chemistry, Heidelberg University, 69120 Heidelberg, Germany
5Department for Bioinformatics and Functional Genomics, Bioquant and Institute of Pharmacy and Molecular Biotechnology,
Heidelberg University, 69120 Heidelberg, Germany
6Division of Theoretical Bioinformatics, German Cancer Research Center (DKFZ), Im Neuenheimer Feld 267, 69120 Heidelberg, Germany
7Section Molecular Immunology, Institute of Immunology, Heidelberg University, 69120 Heidelberg, Germany
8Apogenix AG, Im Neuenheimer Feld 584, 69120 Heidelberg, Germany
9Department of Neurosurgery, University Hospital Ulm, 89312 G€unzburg, Germany
10Center for Integrative Medicine and Physics, Institute for Advanced Study, Kyoto University, 606-8501 Kyoto, Japan
11Present address: Experimental Medical Physics, Heinrich-Heine University D€usseldorf, 40225 D€usseldorf, Germany
12Present address: Institut de Biologie Structurale, Universite´ Grenoble Alpes, Centre National de la Recherche Scientifique, Commissariat a`
l’Energie Atomique et aux Energies Alternatives, 38000 Grenoble, France
13Present address: The Brain Cognition and Brain Disease Institute, Shenzhen Institutes of Advanced Technology, Chinese Academy of
Sciences, Shenzhen, China
14Lead Contact
*Correspondence: tanaka@uni-heidelberg.de (M.T.), a.martin-villalba@dkfz-heidelberg.de (A.M.-V.)
https://doi.org/10.1016/j.celrep.2019.10.054
SUMMARY
The death receptor CD95 is expressed in every
cancer cell, thus providing a promising tool to
target cancer. Activation of CD95 can, however,
lead to apoptosis or proliferation. Yet the molecular
determinants of CD95’s mode of action remain
unclear. Here, we identify an optimal distance
between CD95Ligand molecules that enables
specific clustering of receptor-ligand pairs,
leading to efficient CD95 activation. Surprisingly,
efficient CD95 activation leads to apoptosis in can-
cer cells in vitro and increased tumor growth in vivo.
We show that allowing a 3D aggregation of
cancer cells in vitro switches the apoptotic
response to proliferation. Indeed, we demonstrate
that the absence or presence of cell-cell
contacts dictates the cell response to CD95.
Cell contacts increase global levels of phosphory-
lated tyrosines, including CD95’s tyrosine. A
tyrosine-to-alanine CD95 mutant blocks prolifera-
tion in cells in contact. Our study sheds light
into the regulatory mechanism of CD95 activation
that can be further explored for anti-cancer
therapies.
INTRODUCTION
Cancer is considered a disorder of signaling networks (Giancotti,
2014). Proliferation and survival of cancer cells are controlled by
highly redundant signaling pathways that facilitate the develop-
ment of resistance to molecular therapies (Sever and Brugge,
2015). Thus, therapies aimed at inducing cell death have a higher
chance of avoiding resistance. The CD95 receptor represents an
ideal candidate for targeted therapies, as it is expressed in every
cancer cell and no loss-of-function mutations have been re-
ported. Activation of CD95 in cancer cells may trigger apoptosis
or tumorigenesis (Alderson et al., 1995; Brunner et al., 1995;
Dhein et al., 1995; Ju et al., 1995). The activation of apoptosis
by CD95 requires the assembly of a death-inducing signaling
complex (DISC) composed of the adaptor protein Fas-associ-
ated protein with death domain (FADD) and the initiator Cas-
pase-8 and 10. DISC assembly further activates other effector
caspases in charge of cleaving cell substrates leading to the
cell’s own demise (Scott et al., 2009). On the other hand,
CD95-mediated tumorigenesis has been linked to other
signaling pathways, such as activation of nuclear factor kB
(NF-kB), extracellular signal-regulated kinase (ERK), and phos-
phoinositide 3-kinase (PI3K) (Freiberg et al., 1997; Gulbins
et al., 1998; Desbarats et al., 2003; Barnhart et al., 2004; Legem-
bre et al., 2004; Kleber et al., 2008). Activation of kinase
activities, such as ERK and PI3K, involves the recruitment of
SH2-domain-containing proteins to a tyrosine residue within an
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immune receptor tyrosine-based inhibition/activation-like motif
(ITAM/ITIM) in the death domain (DD) of CD95 to the PI3K-acti-
vating complex (PAC) (Atkinson et al., 1996; Daigle et al., 2002;
reviewed in Sancho-Martinez and Martin-Villalba, 2009). Yet,
how CD95 decides between the assembly of a DISC or a PAC
is fundamentally not understood.
RESULTS
Optimal Induction of Apoptosis in Cancer Cells Occurs
at Specific CD95L Intermolecular Distance and
Correlates with CD95 Cluster Formation
Thedifferential CD95modeof action hasbeen linked to activation
of CD95 by a membrane-anchored CD95Ligand (mCD95L) or
soluble CD95L (sCD95L), leading to activation of apoptosis or
proliferation, respectively (Tanaka et al., 1995; Suda et al.,
1997; Schneider et al., 1998; O’ Reilly et al., 2009). However,
forced expression of CD95L on cells has failed to fight the
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Figure 1. Optimal Induction of Apoptosis
in Pancreatic Ductal Adenocarcinoma
(PanD24) Cells Occurs at Specific CD95L
Intermolecular Distance and Correlates with
CD95 Cluster Formation
(A) Scheme of the experimental setup with PanD24
cells on supported membranes either on control
membraneswithout ligand anchoring ormembranes
displaying CD95L at defined average intermolecular
spacing hdi, highlighted in the left zoomed area. The
interaction of CD95 receptor on cells and CD95L
on membranes are highlighted in the right
zoomed area.
(B) Comparison of apoptosis induction at optimal
hdi = 9 nm, in the presence of sCD95L and in the
absence of CD95L in PanD24 cells.
(C) Dynamics of apoptosis induction in PanD24 cells
at different hdi. The percentage of apoptotic
cells over time is analyzed by a Hill fit (Equation 1,
Table S2).
(D) Cell adhesion area versus hdi, recorded at t = 2 h.
(E) Fluorescence images of PanD24 membrane
contact area of CD95-YFP transfected PanD24 cells
at hdi = 9 nm.
(F) Number of CD95 clusters (R1 mm2) versus hdi,
recorded 10 min before apoptotic blebbing. Control
membranes without CD95L are defined as hdi =N.
n R 90 cells/condition. ***p < 0.001, **p < 0.01,
*p < 0.05.
See also Figure S1, Tables S1 and S2, and Videos
S1 and S2.
response (Chen et al., 1998). Thus, we first
addressed if the arrangement of CD95 re-
ceptor-ligand pairs on the plasma mem-
brane would dominate the cell’s response.
As both CD95 and CD95L are transmem-
brane proteins, we control the binding of
cancer cells expressing CD95 by function-
alizing a substrate with CD95L. To this
end, we designedmembrane-based surro-
gate surfaces (Tanaka and Sackmann, 2005; Burk et al., 2015)
displaying the sCD95L fused to the T4-Foldon motif that was
used as a trimerization domain (Figure 1A; Kleber et al., 2008).
This membrane model system enables quantitative and precise
control of the average intermolecular distance hdi between
mCD95L on the membrane surface by changing the doping ratio
of biotinylated lipid anchors (Table S1; see also STAR Methods
for detailed explanation of hdi calculation). Cancer stemcells iso-
lated from a pancreatic ductal adenocarcinoma patient (PanD24;
Teodorczyk et al., 2015) were incubated with the mCD95L-sup-
ported membrane, and their apoptotic response was monitored
over time by using label-free time-lapse microscopy. Using a
ligand density of 13,200 ligands per mm2, corresponding to
hdi = 9 nm, we observed a rapid rise of the number of apoptotic
cells, which reached 92% with a half time of 36 min (Figure 1B).
In contrast, only 7% of apoptotic cells were observed on amem-
brane with no ligand, confirming that apoptosis results from spe-
cific CD95-mCD95L interactions. Moreover, the same ligand
dissolved in solution (sCD95L; 1 mg/ml) also led to apoptosis.
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The final level of sCD95L-mediated apoptosis reached 70%, but
the kinetics was found to be much slower, showing a lag time of
40 min before an abrupt rise of the number of apoptotic cells.
Characterization of the apoptotic dynamics using a Hill equation
(see STARmethods for definition) revealed that sCD95L requires
a longer lag time (Hill coefficient of n > 3) than mCD95L (Hill coef-
ficient of n 1.5).
This observation leads to the hypothesis that the confinement
of CD95L on the membrane surface can activate the receptor
efficiently and trigger rapid apoptosis. To further test this hypoth-
esis, we measured the apoptotic response for different ligand
densities, with an average hdi ranging from 6 to 17 nm (Table
S1). Strikingly, the level of apoptosis did not increase proportion-
ally with the decrease in hdi but showed the maximum efficiency
of 92% at hdi 9 nm (Figure 1C; Table S2).
To further understand the functional role of hdi in apoptotic re-
actions, we first measured the adhesion area per cell as a func-
tion of hdi (Figure 1D) and found that the adhesion area does not
take the maximum at hdi 9 nm but monotonically increases
with decreasing hdi. These data show that the CD95-mCD95L
pairs anchor the cell to the surrogate surface, hence, increasing
the cell’s adhesion with increased engagement of ligand-recep-
tor pairs, whereas efficient induction of apoptosis requires a spe-
cific arrangement of ligand-receptor interactions.
Moreover, by expressing yellow fluorescent protein (YFP)-
tagged CD95 in PanD24, we observed the accumulation of the
receptors in the adhesion zone (Figure 1E). YFP signals were
diffusive during the early stage of cell spreading (Figure 1E;
10 min), followed by the formation of bright clusters over time
(Video S1). On the other hand, YFP signal was homogenously
distributed on control membranes, 1,2-dioleoyl-sn-glycero-3-
phosphocholine (DOPC) (Video S2). The number of clusters
measured 10 min before apoptosis took the maximum at
hdi = 9–11 nm (Figure 1F). These data suggest that the surface
displaying mCD95L at hdi enables the most efficient binding
and clustering of ligand-receptor pairs, resulting in the strongest
apoptotic signaling. The ligand-receptor pairing was also visual-
ized by fluorophore-labeled neutravidin (NAV) and CD95-GFP
expressing cells (Figure S1). Initially, homogeneous signals
from NAV coupled to mCD95L exhibited a clear accumulation
beneath the cell over time.
It should be noted that the density of ligands calculated from
hdi, 12,000 per mm2, is three orders of magnitude larger than
PanD24 (43000 CD95/cell) GBM60 (5900 CD95/cell) GBM50 (5700 CD95/cell)


































Figure 2. Apoptosis of Primary Cancer Cells
Correlates with CD95 Expression Levels
and Exhibits an Optimal CD95L Distribution
as a Generic Signature
(A) Dynamics of glioblastoma (GBM) cell apoptosis
at hdi = 11 nm.
(B) Percentage of apoptotic cells versus hdi (t = 1 h).
Data of PanD24 at hdi = 11 nm are indicated as
broken lines as reference. nR 70 cells/condition.
See also Tables S3 and S4.
the density of CD95 on PanD24, namely,
13.4 per mm2 (Table S3). Therefore, we hy-
pothesized that the optimal ligand dis-
tance correlates with a critical molecular size of the receptors
but not with the receptor density. To verify this point, we exam-
ined primary cancer cells originating from different glioblastoma
multiforme (GBM) tumors (Drachsler et al., 2016). GBM60 and
GBM50 cells were isolated from two different patients and
both expressed 1.8 CD95 receptors per mm2 (Table S3). With a
ligand intermolecular distance of 11 nm, both cell lines exhibited
apoptotic kinetics similar to PanD24 (Figure 2A). However, the
final number of apoptotic cells was lower, with a plateau at
around 35% for GBM60 and 21% for GBM50, which is 2–3 times
lower than that of PanD24 (Figure 1C). Intriguingly, exactly as we
observed for PanD24, we found that the surface displaying
CD95L at hdi = 9–11 nm most effectively induced apoptosis in
GBM cells (Figure 2B) with the smallest Hill coefficient (Table
S4). Taken together, these data indicate the existence of an
optimal CD95L spacing hdi = 9–11 nm to trigger apoptosis
most efficiently across different cancer cell types.
Furthermore, to decipher whether the difference in signaling
dynamics and efficiency stems from the lateral mobility of
CD95-mCD95L pairs and their re-arrangement on the substrate,
we used 1,2-dipalmitoyl-sn-glycero-3-phosphocholine (DPPC)
membranes in which the lateral mobility of lipid molecules is
significantly suppressed at 37C (Gennis, 1989). On DPPCmem-
branes displaying mCD95L, GBM50, and GBM60, cells died
much slower than on DOPC (Figures 3A and 3E versus Figures
3B and 3F). However, themaximum levels of apoptotic cells after
6 h were comparable to those obtained on fluid DOPC mem-
branes after 3 h. The distinctly slower kinetics of apoptosis can
also be seen by a larger Hill coefficient on DPPC (n = 3–6; Table
S4) with respect to DOPC membranes (n = 1.7–4; Table S4).
Accordingly, the formation of CD95 clusters was significantly
suppressed (Figures 3C and 3G and Figures 3D and 3H), indi-
cating that loss of membrane fluidity suppressed the formation
of death-inducing clusters.
mCD95L-Supported Membrane-Coated Beads Promote
Tumor Growth
So far, our data show that CD95L pre-confined at an optimal
intermolecular distance can effectively trigger CD95-mediated
apoptosis in cancer cells in vitro. Thus, we hypothesized that
this knowledge could be used to efficiently kill tumor cells in vivo.
To this end, we assembled latex beads coated with supported
membranes displaying CD95L at hdi = 9 nm and compared
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with the beads coated with pure DOPC membranes (Figure 4A).
Then, tumor cells were subcutaneously (s.c.) injected into the
flanks of immunosuppressed SCIDbg mice (Figure 4A). The s.c.
location was selected over the brain to avoid beads having to
cross the blood-brain barrier to reach the tumor. To control for
effects arising from activation of CD95 in non-tumor cells, we in-
jected either CD95high, CD95low (sorted as previously described
in Drachsler et al., 2016), or unsorted (bulk) GBM cells. Three
weeks after cell injection, tumors were already detected and,
hence, this time was chosen for intravenous (i.v.) bead injection.
Thereafter, tumor growth was further monitored. To our surprise,
instead of the expected reduction in tumor size, treatment with
CD95L beads exponentially increased growth of bulk or
CD95high tumors. This increase in tumor growth was not present
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Figure 3. Lateral Mobility of Lipids on Sup-
ported Membrane Impacts the Apoptosis In-
duction and CD95 Receptor Clustering.
Inhibition of CD95L mobility by DPPC-supported
membranes results in slowdown of apoptosis in-
duction (A and E) and supression of CD95 cluster
formaion (C andG). Apoptosis induction inGBM cells
is optimal at specific CD95L intermolecular distances
on DOPC-supported membranes (B and F) and cor-
relates with CD95 cluster formation (D and H).
(A and E) Dynamics of apoptosis induction in
GBM50 (A) and GBM60 (E) cells at different hdi on
DPPC. The percentage of apoptotic cells over time
is fitted with a Hill function (Equation 1, see Table S4
and text for fit results).
(C and G) Number of CD95 clusters for GBM50 (C)
and for GBM60 (G) on DPPC-supported mem-
branes at different hdi. Clusters are R1 mm2, and
their number is analyzed 10 min before cell bleb-
bing/apoptosis.
(B and F) Dynamics of apoptosis induction in
GBM50 (B) and GBM60 (F) cells at different hdi on
DOPC (see Table S4 and text for fit results).
(D and H) Number of CD95 clusters for GBM50 (D)
and for GBM60 (H) on DOPC supportedmembranes
at different hdi. nR 40 cells/condition. ***p < 0.001,
**p < 0.01, *p < 0.05.
See also Table S4.
cating that the proliferative effect was
directly driven by CD95 on tumor cells (Fig-
ure 4B). Thus, inflammatory cells or ves-
sels could be excluded as the main drivers
of this pro-tumorigenic effect. Further-
more, the same CD95-dependent tumor
growth was observed in xenograft tumors
derived from another GBM patient (Fig-
ure S2A). Of note, control CD95high tumors
showed a lack of tumor growth in the first
patient (Figure 4B) that we never observed
in CD95high tumors of other patients (Fig-
ure S2A; Drachsler et al., 2016). Such
behavior might indicate a higher depen-
dency of this patient’s tumor cells on
CD95L. The beads could be detected in
several locations, such as the tumor, lung, and liver, showing
no signs of apoptosis in lung and liver (Figures S2B and S2C).
This finding demonstrates that beads coated with mCD95L at
the optimal distance foster proliferation of tumor cells directly
acting by CD95 on these cells in vivo.
To gain further mechanistic insights into the determinants of
the pro-tumorigenic response mode to CD95, we used a synge-
neic orthotopic glioma model (Figure S3A). This model addition-
ally allows study of the cell’s response to CD95 in the natural
environment of the brain in the background of a fully competent
immune system. To this end, cells derived from a spontaneous
murine astrocytoma (SMA560) were intracranially (i.c.) injected
into the striatum of VMDK mice. Five days post tumor cell
implantation, the beads coated with membranes displaying
CD95L at hdi = 8 nm compared with the control beads coated
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with pure lipid membranes were injected i.c. The mice were
sacrificed once the maximum tolerable tumor volume was
reached. Thereafter, brain tumor sections were stained for phos-
pho-ERK (p-ERK), phospho-Histone3 (p-H3), cleaved Caspase-
3, and phospho-Akt (p-Akt) (Figure S3B). The number of cells
positive for p-ERK and p-Akt were significantly higher in tumors
exposed to CD95L beads, compared to control-bead-treated
tumors (Figure S3C). This is in line with previous studies demon-
strating that the pro-tumorigenic CD95-signaling cascade in-
volves activation of the ERK and/or PI3K signaling pathways
(Kleber et al., 2008; Martin-Villalba et al., 2013; Teodorczyk
et al., 2015). A clear increase in the mitotic index of tumors
treated with CD95L beads compared to control beads was as-
sessed by p-H3 staining (Figures S3B and S3C). On the other
hand, there was no difference in the number of cells undergoing
apoptosis between the two groups, as assessed by staining of
cleaved Caspase-3 (Figures S3B and S3C). Based on these
data, we concluded that CD95-dependent proliferation of cancer
cells highly correlates with increased activation of Ras/ERK and
PI3K signaling pathways.
Presence of Cell-Cell Contact Switches the Apoptotic
Response to Proliferation
What is the origin of these antithetic cellular responses observed
in vivo and in vitro? One apparent difference is that the cells
in vivo were immersed in the multicellular network of three-
dimensional tumors, whereas the in vitro experiments were per-
formed using isolated single cells on planar surfaces. To test if
the different cell responses originate from cell-cell interactions,
we investigated the functional outcome of mCD95L stimulation
of cancer stem cells within three-dimensional tumorspheres
in vitro. The self-renewal was assessed by counting the number
of tumorspheres as a function of hdi. Surprisingly, also in vitro,
exposure of tumorspheres to mCD95L-supported membranes
triggered a significant increase of self-renewal (Figure 5A)
instead of apoptosis (Figure 5B). Importantly, the maximum
sphere number (38 ± 3) was found at the optimal distance hdi
(Figure 5A). Similar behavior was also observed in PanD24 tu-
morspheres, while the highest number of spheres was detected
at hdi = 17 nm (Figure S4A). Based on our data, we concluded
that the confinement of CD95L at hdi enhanced the self-renewal
most efficiently in solid tumors in vivo and tumorspheres in vitro.
To test the physiological relevance of the identified optimal dis-
tance and the presence of cell-cell contact, we turned to a non-
neoplastic cell system of cells that are naturally in contact with
each other. We have previously shown that activation of CD95
on myeloid cells enhances their rolling and adhesive behavior,
facilitating recruitment to the inflammatory site (Gao et al.,
2016). Accordingly, mouse bone-marrow-derived neutrophils
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Figure 4. CD95L-Coated Beads Promote Subcutaneous Tumor Growth
(A) Scheme of the patient-derived tumor xenograft model (GBM39). Cancer cells are fluorescence-activated cell sorting (FACS)-sorted according to CD95
surface expression levels and grown in mice subcutaneously before the intravenous (i.v.) injection of the beads. Either non-functionalized DOPC-membrane-
coated beads (control beads) or CD95L functionalized beads were injected.
(B) Kinetics of tumor progression upon bead injection (control beads = gray data, n = 3; CD95L beads = green data, n = 4–5). CD95L distance on beads hdi = 9 nm.
Values are mean ± SEM; two-way ANOVA, **p < 0.0013.
See also Figure S2 and S3.
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assay. Now, we show that neutrophils increased ICAM-1 binding
upon mCD95L stimulation at a specific intermolecular distance
(hdi = 11–17 nm) (Figure S4B). In addition, we have previously
shown that CD95 activation of endothelial cells controls vessel
branching in the developing cortex and retina (Chen et al.,
2017a). Therefore, we exposed human endothelial cells (HU-
VECs) to mCD95L at different intermolecular distances of
CD95L (Figure S4C). Indeed, only mCD95L presented at the
optimal intermolecular distance increased angiogenic activity
but not apoptosis of HUVECs (Figures S4D–S4G). Thus, a unique
intermolecular distance controls CD95’s activation mode in
neoplastic and healthy cells.
Next, we addressed if the presence of merely one or two cell-
cell contacts would be enough to shift the response of the cell
to CD95 activation away from apoptosis. Therefore, we moni-
tored and compared apoptosis of GBM50 cells either exhibiting
up to two cell-cell contacts or as isolated cells on the same
supported membranes (Figure 5C; Video S3). GBM cells in con-
tact with other cells exhibited a distinct lower fraction of
apoptosis induction (reduction by 2-fold) for all hdi conditions
compared to isolated cells. Moreover, the cells from other GBM
patients, as well as HeLa cells from another cancer type (cervi-















































































Figure 5. CD95 Activation Enhances Self-
Renewal Capacity of Tumorspheres
(A) Patient-derived glioma sphere cultures (GBM50)
were treated for 4 h with CD95L-coated membranes
and were subsequently plated for sphere formation
assessment. Values are mean ± SEM.; one-way
ANOVA, *p < 0.02, ***p < 0.0002.
(B) TUNEL assay for GBM50 tumorspheres was
performed to assess apoptotic cells after 4-h treat-
ment with CD95L-coated membranes. Values are
mean ± SEM.
(C and D) Apoptotic behavior of GBM50 in contact
with other cells on DOPC (C) and DPPC (D) mem-
branes functionalized with CD95L at different hdiwas
analyzed at t = 200 min. Broken line: data of isolated
individuals. n R 40 cells/condition. Values are me-
dian ± median absolute deviation (MAD).
See also Figures S4 and S5 and Videos S3, S4,
and S5.
with other cells (Figures S5A and S5B,
broken lines). With this knowledge, we hy-
pothesized that the difference in final num-
ber of apoptotic cells between PanD24
cells (92%) and GBM cells (21%–35%)
could be due to differences in their ten-
dency to form clusters with neighboring
cells. To validate this hypothesis, we
analyzed the cohesive behavior of these
cells on the mCD95L membranes. GBM
cells were highly mobile and showed a
high tendency to adhere to neighboring
cells by forming protrusions leading to the
establishment of cell-cell contacts (Fig-
ure S5C; Video S4). However, PanD24
cells did not exhibit a pronounced cell motion but remained
attached to the mCD95L-coated membrane (Figure S5D; Video
S5). In both cell types, apoptosis induction of single cells was
observed while examples of cell divisions were found in the
presence of cell-cell contacts. In summary, in solid tissues
where cells are in contact with neighboring cells, CD95 activa-
tion promotes pro-survival signaling, whereas the loss of cell-
cell contact renders CD95-stimulated cells sensitive to undergo
apoptosis. Notably, the same tendency was observed on DPPC
membranes (Figure 5D; Figures S5E and S5F), suggesting the
bifurcation between apoptosis and proliferation does not
depend on the mobility of CD95L molecules. The obtained re-
sults suggest that the apoptosis kinetics is strongly influenced
by intermolecular distance between CD95L hdi and the lateral
mobility of CD95L, whereas the mode of cellular response,
i.e., apoptosis versus proliferation, is determined by the pres-
ence or absence of cell-cell contacts.
Cell-Cell Contact Increases Global Tyrosine Kinase
Activity That Is Required for CD95 Activation-Induced
Self-Renewal of Tumorspheres
How does cell-cell contact influence the cell response to CD95
activation? It has been shown that signaling of apoptosis requires
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Figure 6. Cell-Cell Contact Increases Global Tyrosine Kinase Activity
(A) Representative images of GBM6 single cells, doublets in 10-cm plate, and spheres in 6-well plate format are shown. The cells were seeded at 0.5 3 106 cell
density; time after accutase dissociation is indicated below the images. Scale bar, 50 mm.
(B) Experimental setup for western blot analysis of single versus spheres.
(legend continued on next page)
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the recruitment of DISC to CD95 DD, whereas proliferation in-
volves phosphorylation of residue Y291 located within the DD
(Kleber et al., 2008; Chakrabandhu et al., 2016; Drachsler et al.,
2016). In light of this knowledge, we hypothesized that cell-cell
contact might favor tyrosine phosphorylation over DISC assem-
bly. First, we defined the cell plating settings to obtain single cells,
doublets, and spheres (Figure 6A). Indeed, the presence of
cell-cell contact globally increased the levels of tyrosine-phos-
phorylated proteins compared to levels exhibited in single cells,
as detected with a generic anti-phosphotyrosine (pTyr) antibody
(Figures 6B and 6C). Next, we investigated global pTyr levels in
naturally occurring single cells and doublet cells by imaging
flow cytometry (Figures 6D and 6E; see Figures S6A and S6B
for more representative images of cells and Figures S6C–S6F
for experimental settings). This method allowed us to discrimi-
nate singlet and doublet cells and image 10,000 cells per sam-
(C) Western blot analysis of single cells versus spheres from GBM60 and GBM10, probed for pTyr antibody. Same membranes were incubated with anti-Histone
H3 antibody for loading control.
(D) Experimental setup for imaging flow cytometry analysis of single cells versus doublets.
(E) Examples of inflow microscopy images of nuclei (DAPI), pTyr-PE, and F-actin (AF488) in singlet versus doublet. Scale bar, 7 mm. A 603 objective was used.
(F) A representative histogram and quantification of pTyr signal in singlet versus doublets by imaging flow cytometry.
(G) Geometric mean fluorescence intensity (MFI) from doublet/singlet gates were plotted for pTyr and F-actin signals. 10,000–20,000 cells per sample were
analyzed (n = 4). Values are mean ± SEM. t test, *p < 0.05.




Figure 7. CD95 Tyrosine Phosphorylation Is
Increased in Spheres and Is Required for
CD95-Activation-Induced Self-Renewal of
Tumorspheres
(A) Experimental setup for mass spectrometry analysis
of pTyr immunoprecipitation (pTyr IP) samples from
CD95-WT or CD95-Ala-overexpressing cells.
(B) Normalized CD95 signal (LFQ) was detected by MS/
MS from pTyr IP samples either CD95-WT or CD95-Ala-
overexpressing tumorspheres (GBM6) treated with
CD95L antibody (Apo-1) for 5 min. The fold change was
calculated from the ratio of CD95 signal in IP over flow
through (FT) for each sample (n = 2).
(C and D) CD95-WT (C) overexpressing or CD95-Ala (D)
mutant overexpressing glioma cells (GBM6) were treated
as spheres for 4 h on CD95L-coated membranes at dif-
ferent hdi. Subsequently, they were plated to measure
the sphere-forming capacity. Values are mean ± SEM;
t test, *p < 0.05; **p < 0.01; ****p < 0.0001. n = 3.
See also Figure S7.
ple. Thereafter, we performed control experi-
ments for pTyr staining after a physiological
stimulus, epidermal growth factor (EGF), or af-
ter a phosphatase inhibitor, vanadate treat-
ment (Figures S6G and S6H). Upon these
treatments, global pTyr levels were also
increased, and importantly the highest level
was reached by vanadate treatment (Fig-
ure S6H). Similar to western blot results, the
levels of pTyr per cell weremuch higher in dou-
blets (2.753 ± 0.237 fold-change, n = 4) than in
single cells compared to the actin signal
(2.124 ± 0.093 fold-change, n = 4) (Figures 6F and 6G). Thus,
we conclude that the presence of cell-cell contact increases
global levels of tyrosine kinase activity.
To confirm the importance of phosphorylation of the tyrosine
motif in CD95-mediated proliferation, we generated GBM6 cells
stably overexpressing either wild-type CD95 (CD95-WT) or
CD95-alanine mutant (CD95-Ala) that substitutes the Y291 resi-
due of the human CD95 by alanine (Figure 7A). We detected
CD95 within the pool of phosphorylated proteins obtained from
pTyr immunoprecipitation (IP) and analyzed by liquid chromatog-
raphy-tandem mass spectrometry (LC-MS/MS). The quantified
CD95 signal was lower in CD95-Ala expressing tumorspheres
than CD95-WT cells (Figure 7B). Of note, the total number of
identified peptides and proteins were similar in all samples (Fig-
ures S7A and S7B). Consistently, the control proteins containing
pTyr sites irrelevant to CD95 signaling were enriched at a similar
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level in the IP samples (Figures S7C and S7D). Upon exposure of
these cells to CD95L surrogate membranes, the self-renewal ca-
pacity of the CD95-Ala cells was significantly impaired
compared to the CD95-WT cells (Figures 7C and 7D). These
data highlight the critical regulation of survival at the DD of
CD95 and the requirement of tyrosine kinase activity to drive
the cell response to CD95 toward activation of proliferation
signals.
DISCUSSION
In this study, we unveil two levels at which CD95-mediated
signaling is controlled. First, the optimal arrangement of recep-
tor-ligand pairs on the surface of plasma membranes controls
the receptor-activation efficiency. Second, the cell-cell contacts
increase the tyrosine phosphorylation globally, thereby deciding
whether the cell undergoes apoptosis or rather activates a sur-
vival program.
We have established membrane-based surrogate cell sur-
faces displaying mCD95L to study CD95 activation in cancer
cells. This system revealed an optimal mCD95L intermolecular
distance as the most efficient to trigger CD95 cluster formation
and, thereby, apoptosis in primary cancer cells in vitro. In partic-
ular, the reconstitution of mCD95L on the supported membrane
at an intermolecular distance hdi = 9–11 nm was found to maxi-
mize the efficiency and kinetics of receptor activation. In addition
to cancer cells, endothelial cells and myeloid cells selectively
respond to this ‘‘optimal intermolecular distance’’ of CD95L
with an angiogenesis or integrin activation, respectively. Thus,
suggesting the selective activation of CD95 signaling by
CD95L presented at this distance hdi is a universal feature.
Hitherto, the discrepancy between different forms of CD95L to
induce apoptosis has been based on an earlier study that used
a mouse model expressing a constitutively cleaved ligand and
lacking the membrane-bound form of CD95L (O’ Reilly et al.,
2009). They proposed that the observed glomerulonephritis
and liver tumors are due to inflammatory functions of circulating
sCD95L, as this is not or rarely observed in CD95L mutant gld
mice (Lynch et al., 1994). However, CD95L-deficient mice do
show glomerulonephritis and probably do not develop liver tu-
mors due to their mortality at very young age (Karray et al.,
2004). These data can be interpreted differently, as the lower ac-
tivity of sCD95Lmight be compensated by a higher production of
CD95L that would then be able to reach higher concentrations
and delay the symptomatic manifestations compared to
CD95L deletion. Along this line, our data highlight that the
same cellular responses are elicited by sCD95L and mCD95L
but with a much lower activity and slower signal activation in
the case of sCD95L.
Moreover, we found that the formation of CD95 clusters
scaled with apoptosis induction, where the maximum cluster
number was also observed at hdi. To date, the structural infor-
mation regarding the CD95-CD95L pairs has not been resolved,
and yet, the high similarities in the tumor necrosis factor/tumor
necrosis factor receptor (TNF/TNFR) family indicate shared
properties of ligand-receptor binding (Nagata, 1997; Li et al.,
2013). Accordingly, interactions betweenCD95L and its receptor
were assumed to occur in three-to-three mode (Valley et al.,
2012). Previous structural studies also unveil a model in
which the extracellular ligand/receptor interactions further coop-
erate with intracellular receptor/FAS-associated death domain
protein (FADD)/Caspase-8 interactions through assembly in
DD/DD oligomerization. Consequently, the formation of higher
order assemblies can initiate CD95 signaling (Siegel et al.,
2004; Scott et al., 2009; Wang et al., 2010). In line with this
model, we have observed the formation of the large CD95
receptor clusters on mCD95L-supported membranes. A rigid-
body-based computational model of membrane receptor-ligand
interactions further illustrated that confining the structural flexi-
bility of receptors by membrane topology has an influence on
the binding to its ligand (Chen et al., 2017b).Modification of intra-
molecular flexibility could optimize the binding between ligand
and receptors. Indeed, our data show that the anchoring of li-
gands on membrane surfaces as well as the fine adjustment of
inter-ligand distance hdi have a major influence on the receptor
activation, compared to soluble ligands. In addition to the pro-
posed oligomerization models, a growing body of evidence
suggests that post-translational modifications (PTMs), particu-
larly glycosylation and palmitoylation, can contribute to the
high-order clustering of TNFRs, including CD95, upon ligand
activation or at resting pre-ligand state (reviewed in Micheau,
2018; Siegel et al., 2004; Feig et al., 2007). In support of this,
the formation of CD95 clusters was found to be dependent on
palmitoylation, and the palmitoylated CD95 localized to lipid
rafts, as confirmed by photo-activated localization microscopy
(PALM) imaging (Cruz et al., 2016).
In addition, the systematic comparison of our results obtained
from isolated single cells, tumorspheres in vitro, and tumor
growth in vivo enabled identification of ‘‘cell-cell contact’’ as a
major switch of the CD95-mediated cell response from
apoptosis to survival. Along this line, in colon epithelial cells,
sequestration of CD95 at adherens junctions was shown to
inhibit apoptosis through reduced binding capability to CD95L
and by formation of a complex with cell polarity molecule Dlg1
that impairs DISC assembly (Gagnoux-Palacios et al., 2018).
Our study shows that in addition to inhibition of apoptosis,
cell-cell contact facilitates tyrosine phosphorylation of CD95-
DD and, thereby, PAC assembly. Similarly, the impact of cell-
cell contact on cell-fate decision has been demonstrated in the
recent studies. In Drosophila pupa, the weakening/loosening of
cell contacts leads to a reduction of PIP3 levels, which, in turn,
triggers elimination of looser phenotype by apoptosis (Levayer
et al., 2015). Additionally, in cancer cells, a switch of cell
migration to proliferation occurs by cell-cell contact-mediated
vesicular recycling of EGF receptor (EGFR) that leads to the
maintenance of ERK activity (Stallaert et al., 2018). Recent
studies demonstrate as well that metastatic tumor cells need
to be associated in cell clusters together with neutrophils for
cell cycle progression (Gkountela et al., 2019; Szczerba et al.,
2019), similarly to the correlation of CD95-induced cell divisions
and cohesive behavior of cancer cells observed in this study. On
a molecular scale, cell-cell contact may energetically favor
segregation of proteins or formation of multiprotein complexes,
generating domains with a distinct kinase activity, as shown for
the T cell receptor (Grakoui et al., 1999; Barthe´le´my et al.,
2000; James and Vale, 2012). Cell-cell contact can provide
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spatial cues that coordinate receptor tyrosine kinase (RTK) local-
ization and activity and eventually act as a global regulatory
mechanism on cell-cell communication and tissue homeostasis
(reviewed in Chiasson-MacKenzie andMcClatchey, 2018). Thus,
the observed increase in global tyrosine-kinase activity might
involve integrins (Aoudjit and Vuori, 2000) and/or RTK-like
EGFR (Bivona et al., 2011) that leads to transactivation of
CD95. Consistently, EGFR-mediated phosphorylation of CD95
(pY291) leads to proliferation (Ta et al., 2018). Previously, this
tyrosine residue (Y291) was found to be susceptible to phos-
phorylation through members of the Src-family kinases (SFKs),
but this modification was considered to be proapoptotic (Atkin-
son et al., 1996; Gradl et al., 1996). The adaptor proteins and SFK
members involved in the interaction with the Y291 at DD of CD95
also differ depending on the cell type. For example, in GBM and
NSC cells, PI3K is activated by different SFK members, namely,
Yes and c-Src, respectively (Kleber et al., 2008; Corsini et al.,
2009; Chakrabandhu and Hueber, 2016), whereas in immune
cells, Syk, Fyn, and Lck play a role in SFK-mediated interaction
with CD95 (Atkinson et al., 1996; Schlottmann et al., 1996; Letel-
lier et al., 2010). On the other hand, ERK andPI3K are activated in
pancreatic cancer cells by adaptor protein Sck (Teodorczyk
et al., 2015).
Altogether, our results indicate that the presence of cell-cell
contact globally increases tyrosine kinase activity, leading to
phosphorylation of the tyrosine residue within the DD of CD95
and final engagement of a survival program. Also, this study
highlights how cellular architecture, specifically physical contact
with neighboring cells, can fine-tune the cellular response to
CD95 activation.
Blocking non-apoptotic functions of CD95 is a promising
therapy option for cancer. Accordingly, a phase II clinical trial
in glioblastoma patients by using a fusion CD95-FC protein
that neutralizes CD95L and, thus, CD95 activity increased the
overall survival of patients with the unmethylated-CD95L pro-
moter (Wick et al., 2014). Yet, as reported for previous strategies
targeting kinase activities, other receptors might take over, lead-
ing to therapy resistance in the long term (Xu and Huang, 2010).
Our study unveils a strategy to convert the tumorigenic signal
into apoptosis by targeting tyrosine phosphorylation at DD of
CD95 and, thereby, avoid the risk of therapy resistance to
neutralizing CD95 therapies for cancer patients.
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STAR+METHODS
KEY RESOURCES TABLE
REAGENT or RESOURCE SOURCE IDENTIFIER
Antibodies
Anti-human CD95 (aApo-1) Apogenix GmbH, Germany N/A
Goat-anti-mouse phycoerythrin-conjugated Dianova, Germany Cat# 115-116-071; RRID: AB_2338626
Anti-human IgG1 phycoerythrin-conjugated Southern Biotechnology, USA Cat# 9054-09; RRID: AB_2796628
Anti-CD11b Novus, USA Cat# NB110-89474; RRID: AB_1216361
Anti-phospho-ERK Cell Signaling Technology, Germany Cat# 4370; RRID: AB_2315112
Anti-phospho-AKT Ser 473 Cell Signaling Technology, Germany Cat# 9271; RRID: AB_329825
Anti-cleaved-Caspase-3 Cell Signaling Technology, Germany Cat# 9661; RRID: AB_2341188
Anti-human-Ki67 Novus, USA Cat# NB600-1252; RRID: AB_2142376
Anti-phospho-Histone 3 (immunohistochemistry) Millipore/Merck, Germany Cat# 06-570; RRID: AB_310177
Anti-Pan-Phosphotyrosine Millipore/Merck, Germany Cat# 05-321; RRID: AB_309678
Anti-Pan-Phosphotyrosine phycoerythrin-conjugated Millipore/Merck, Germany Cat# FCMAB323PE; RRID: AB_10805942
Histone H3 (Western Blot) Cell Signaling Technology, Germany Cat# 9717; RRID: AB_331222
Bacterial and Virus Strains
Lentiviral vector CMV-pEIGW-CD95-Ires-GFP Martin-Villalba lab N/A
Lentiviral vector CMV-pEIGW-CD95Y291A-Ires-GFP Martin-Villalba lab N/A
pMD2.G VSV G helper plasmid Lentivirus Trono lab (personal communication) Addgene #12259
PsPAX2 helper plasmid Lentivirus Trono lab (personal communication) Addgene #12260
Lentiviral vector CMV-pEIGW-CD95-YFP Martin-Villalba lab N/A
Biological Samples
Human tumor biopsies from glioblastoma patients University Hospitals, Mannheim, Charite´
Berlin and Ulm/G€unzburg, Germany
N/A
Human tumor biopsies from Pancreatic ductal
adenocarcinoma patients
University Hospital Heidelberg, Germany N/A
Chemicals, Peptides, and Recombinant Proteins
1,2-dioleoyl-sn-glycero-3-phosphocholine (DOPC) Avanti Polar Lipids, USA #850375C
18:1 Biotinyl Cap PE (biotin-DOPE) Avanti Polar Lipids, USA #870273C
1,2-dipalmitoyl-sn-glycero-3-phosphocholine (DPPC) Avanti Polar Lipids, USA #850355C
Neutravidin (deglycosylatedavidin) Life Technologies, Germany #A-2666
Phalloidin-Alexa 488 Thermo Fisher, USA #12379
Recombinant human EGF Promocell #C-60170
Recombinant basic FGF Pelobiotech, Germany #PB-ZAF3007-50
NH4OH Sigma Aldrich, USA #13360
Triton X-100 Sigma Aldrich, USA #x100-100ml
Saponin Sigma Aldrich, USA #S4521-10G
Bovine Serum Albumin Sigma Aldrich, USA #05479-50G
Recombinant Human ICAM-1/CD54 Fc R&D systems, USA #796-IC-050
Polydimethylsiloxane Dow Corning Co., USA
Chloroform Sigma Aldrich, USA #C2432-500ML
Roti-Histofix 4% Carl Roth, Germany #P087.1
Fluoromount-G Biozol, Germany #0100-01
Calcein AM, Live cell dye Life Technologies, Germany #C34852
Proteinase inhibitor Cocktail Complete Roche #11697498001
Sodium Ortho Vanadate Sigma Aldrich, USA #S-6508
(Continued on next page)
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Phosphatase Inhibitor Cocktail Cell Signaling Technology, USA #5870S
Pierce IP Lysis Buffer Pierce/Thermo Fisher, USA #87788
Hoechst 33342 Biotrend, Germany #40047
Gelatin solution Sigma Aldrich, USA #G1393-100 ml
Biotinylated human CD95L trimer (CD95L-T4-btn) Apogenix GmbH, Germany N/A
Critical Commercial Assays
QIFIKIT (measures average amount of CD95
receptors on cell surfaces)
Dako, Germany #K007811
EGM-2 SingleQuot Kit (Supplements and Growth
Factors for endothelial cells
Lonza, USA #CC-4176
Experimental Models: Cell Lines
Human derived primary Glioblastoma cells (GBM) University Hospitals Mannheim, Berlin
(Charite´) and Ulm/G€unzburg, cultured
in the laboratory of Ana Martin-Villalba,
DKFZ, Heidelberg
N/A
Human derived primary Pancreatic ductal
adenocarcinoma cells (PanD24)
University Hospital Heidelberg, cultured
in the Laboratory of Ana Martin-Villalba,
DKFZ, Germany
N/A
Spontaneous murine Astrocytoma-560 (SMA-560) Laboratory of Anne Regnier-Vigouroux,
DKFZ, Germany
N/A
Murine primary Neutrophils Laboratory of Ana Martin-Villalba, DKFZ,
Germany
N/A
Human endothelial cells (HUVEC) Lonza, USA #C2519A
Experimental Models: Organisms/Strains
Mouse/VMDK Central animal facility at DKFZ, Germany N/A
Mouse/CB17-SCID (CB17.Cg -PrkdcscidLystbg-J/Crl) Charles River Strain Code:250
C57BL/6J Charles River Strain Code:027
Software and Algorithms
ImageJ/Fiji NIH, USA https://imagej.nih.gov/ij/download.html
Cell Quest Software Becton Dickinson, Germany N/A
IDEAS 6.0 Software Amnis/Millipore, USA N/A
Mascot Software Matrix Science, USA N/A
MATLAB MathWorks N/A
Other
Dulbecos Modified Eagle Medium (DMEM):HAM’s
nutrient mixture F12
Thermo Fisher, USA #21331-020
Neurobasal Medium A Life Technologies, Germany #10888022
RPMI 1640 Medium Life Technologies, Germany #21875-034
Hanks Balanced Salt Solution (HBSS) Life Technologies, Germany #14170138
Endothelial basal Medium-2 (EBM-2) Lonza, USA #CC-3156
B27 Supplement Life Technologies, Germany #17504044
N2-Supplements Life Technologies, Germany #17502048
L-Glutamine Life Technologies, Germany #25030024
Heparin Sigma Aldrich, USA #H3149-100KU
Accutase Thermo Fisher, USA #A6964
Trypsin-EDTA Life Technologies, Germany #25300096
Plastic fluidic channels m-Slide VI0.4 IBIDI, Germany #80608
Glass slides Menzel GmbH, Germany #BB024060A1
(Continued on next page)
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LEAD CONTACT AND MATERIALS AVAILABILITY
Further information and requests for mouse strains, resources, and reagents should be directed to and will be fulfilled by the Lead
Contact, Ana Martin-Villalba at a.martin-villalba@dkfz-heidelberg.de. This study did not generate other new unique reagents.
EXPERIMENTAL MODEL AND SUBJECT DETAILS
Animal Studies
C57BL/6J WT and CB.17SCID/bg mice were purchased from Charles River. VMDK mice were bred by the in-house animal facility
German Cancer Research Center (DKFZ). Littermate controls were used where appropriate. Mice were maintained in specific
pathogen-free animal facilities at German Cancer Research Center (DKFZ) (Heidelberg, Germany). All animal experiments were
performed in accordance with the institutional guidelines of the German Cancer Research Center and were approved by the
Regierungspra¨sidium Karlsruhe, Germany.
For subcutaneous injection of tumor cells and i.v. injection of coated beads, CB.17SCID/bg mice (8 10 weeks old, female) were
subcutaneously transplanted with 10000 GBM cells in 100 ml matrigel. Tumor size was measured every week with a caliper and after
establishment of tumors, mice were intravenously injected with 2 3 106 DOPC or 1% beads through the tail vein. Two weeks later
animals were sacrificed and tumors were retrieved after transcardial perfusion.
For, orthotopic injection of tumor cells and coated beads, SMA-560 tumor cells were transplanted into 8 to 10 week old, female
VMDK mice (in house breeding). Therefore, 5000 tumor cells were re-suspended in 2 ml of Hanks buffered saline solution (HBSS)
and loaded into a 10 ml nanofill syringe (WPI) and stereotactically injected into the striatum (2.5 mm lateral of the bregma to a depth
of 3 mm) of isofluorane-anaesthetized mice. Five days post-injection 2 3 106 control beads (DOPC) or CD95L-coated beads
(1%Beads) were inoculated at exactly the same position as the tumor cells before. On reaching the no-go criteria, which are declined
in the animal permission, mice were sacrificed and brains were retrieved after transcardial perfusion.
For perfusion,micewere anesthetized by intraperitoneal injection of 800 ml perfusion solution. After the thoracic cavity was opened,
the heart was exposed and transcardial perfusion was performed with 10 mL HBSS. For immunohistochemistry, the mice were addi-
tionally perfused with 10 mL of 4% PFA.
Cell Culture
Collection of patient samples was approved by the Ethics committees of the Charite´ University Medicine, Campus Virchow-Klinikum,
Berlin (EA3/023/06) and Heidelberg University, Medical Faculty (S-233/2016). The information of the age/sex of patients is not avail-
able with regard to patient privacy protection. The specimenwas examined by a neuropathologist to confirm that the tumormetWHO
criteria for glioblastoma. The sample was dissociated using the Brain Tumor Dissociation Kit (P) (MiltenyiBiotec GmbH, Bergisch-
Gladbach, Germany) and subsequently expanded in Neurobasal medium supplemented with B27 (2 vol.%), 2 mM L-glutamine,
heparin (2 mg/ml), EGF (20 ng/ml) and bFGF (20 ng/ml) at 5% CO2 and 37
C.
Glioblastoma multiforme (GBM) stem cells were established from mechanically and enzymatically dissociated brain tumor sam-
ples (GBM6, GBM10, GBM39, GBM50, GBM60). The cells were cultured in serum-free medium containing stem-cell mitogens as
mentioned above. Prior to experiments, the agglomerated cells were centrifuged and re-suspended with Accutase (ThermoFisher)
to get a single cell suspension, which was further diluted in freshly prepared cell culture medium to concentrations of 2 3 105
cells/ml.
SMA-560 and HeLa cells were maintained in DMEM supplemented with 10% fetal calf serum, 1 x glutamine and 1 x penicillin/
streptomycin. Cells were kept in 5% CO2 at 37
C.
METHOD DETAILS
Preparation of Supported Membranes
Before the assembly of sample chambers, glass substrates were cleaned by a modified RCA protocol (Kern and Puotinen,
1983): briefly, samples were sonicated for 5 min in acetone, ethanol, methanol, and water, then immersed in a solution of H2O2
(30%) / NH4OH (30%) / H2O (1:1:5 by volume) and sonicated for 5 min at room temperature before soaking them for another
30 min at 60C. Afterward, glass substrates were intensively rinsed with water, dried at 70C, and stored in a vacuum chamber.
Continued
REAGENT or RESOURCE SOURCE IDENTIFIER
Penicillin and streptomycin Thermo Fisher, USA #15140-122
Porous silica microspheres (NUCLEOSIL
100-10C18) (10 mm)
Macherey-Nagel, Germany #712150.10
De-ionized ultrapure water Genpure, TKA, Germany #50131256
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Sample chambers were individually assembled by bonding the cleaned glass slides (253 75 mm, Menzel GmbH, Braunschweig,
Germany) to plastic fluidic channels (m-slide VI, ibidi, Munich, Germany). Polydimethylsiloxane produced from base and curing agent
(SYLGARD184, Dow Corning Co., USA) served as bonding agent.
Supported membranes were prepared by drying stock solutions of either DOPC or DPPC containing 0.2, 0.5, 0.8, 1.0 and
1.5 mol % biotin-DOPE in chloroform in a nitrogen stream. Dried samples were kept in a vacuum chamber at 25C for 12 h, and
were re-suspended in de-ionized water to a concentration of 1 mg/ml. Small unilamellar vesicles (SUVs) were prepared by pulsed
sonication of the lipid solution using a tip sonicator (Misonix, New York, USA) for 30 min at 1.0 W. Subsequently, SUV suspensions
were incubated on the cleaned, bonded sample chambers where they formed a lipid bilayer on the glass surface. After 45 min. of
incubation, the chambers were intensively rinsed with de-ionized water to remove remaining SUVs. Subsequently, the supported
membranes were incubated with 1 mg/ml neutravidin solution for 30 min and were thoroughly washed with de-ionized water.
Next, the membranes were incubated with aqueous CD95L-T4-btn (2 mg/ml) solution for 1 h at room temperature. Finally, the sam-
ples were carefully washed with pre-warmed cell culture medium and kept at 37C prior to cell experiments.
CD95L-Containing Supported Membrane on Silica Beads
SUVs prepared as described above were used to form supportedmembrane on porous silica microspheres (NUCLEOSIL standard
C18 phases, nonpolar fromMacherey-Nagel, D€uren, Germany). Lipid vesicles were incubated with silica beads at 60C for 2 h under
rotation. The lipid-coated beads were collected by centrifugation and washed with PBS. CD95L functionalization of the supported
membrane on the beads was performed as described above. Here, the beads were kept on a shaker during each incubation step.
Cell Imaging
Cell death wasmeasured bymicroscopy using transmitted light imaging and cell morphology analysis. Images were taken on a Leica
SP5 confocal microscope (Leica Microsystems, Mannheim, Germany) or on an OlympusCKX41 wide-field microscope equipped
with an Olympus PEN Lite CCD camera (Olympus Europa, Hamburg, Germany). Cell death kinetics were quantified from images
taken every 10 min and by manually marking the first rounding and shrinkage event due to cell death. Marks were then automatically
segmented and counted in ImageJ.
To obtain statistically reliable data, we collected results from 3 independent measurements for each experimental condition. For
every single experiment, cellular concentration of 106/ml were plated per channel of the 6 channel chambers. The total number of
cells was counted from 5 - 8 phase contrast images. Time-lapse images were recorded on a fully automated Leica SP5 confocal mi-
croscope (Leica Microsystems, Mannheim, Germany) equipped with an Apo 63 x NA 1.4 oil immersion objective using a proprietary
macro for auto-focusing and multi-position imaging.
The microscope stage was maintained at 37C and CO2 at 5%. Apoptotic cells were identified by monitoring irreversible cell bleb-
bing and fragmentation of cell nuclei. The area of cell adhesion andCD95-GFP clusters were detected bymorphological identification
and intensity threshold. Images were analyzed using ImageJ/Fiji (NIH,USA) as well as routines written in MATLAB (R2013b, TheMath
Works Inc, MA, USA) following cell segmentation scripts (Monzel and Mo¨hl, 2016).
Lentiviral Transductions
For PanD24, cells were infected with lentiviral vector pEIGW-CD95-YFP at amultiplicity of infection (MOI) of 5. Expression of all trans-
genes was confirmed in infected cells by FACS analysis of YFP expression.
For lentiviral infections, GBM cells were sorted for CD95 negative surface expression (CD95neg cells). CD95neg cells were infected
with the lentiviral vector pEIGW-CD95-Tyr (Y291) or pEIGW-CD95-Ala (A291) at a multiplicity of infection (MOI) of 5. The plasmids
were constructed by site directed mutagenesis to exchange the tyrosine residue (Y291) to alanine in the DD of CD95 in pEIGW-
CD95-Tyr. All lentiviruses were propagated using previously described methods (Zuliani et al., 2006). Expression of all transgenes
was confirmed in infected cells by FACS analysis of GFP expression. The percentage of infected cells was 60%–80%. The GFP pos-
itive cells were sorted according to their expression level and expanded for further experiments.
Quantification of CD95 Receptor Levels Presented on the Cell Surface
For the comparison of adhesion/apoptosis behaviors between different cells, the average amount of CD95receptors expressed on
each cell type was calculated by FACS analysis using QIFIKIT (Dako) according to manufacturer’s protocol. Briefly, a calibration
curve was constructed using calibration beads followed by determination of CD95 molecules on the cell surface. For CD95 staining,
aApo-1 (Apogenix, 0.01 mg/ml) was incubated for 20 min on ice, followed by incubation of the secondary antibody (1:30 goat-anti-
mouse phycoerythrin-conjugated; Dianova) for 30 min. Flow cytometry analysis was performed on a FACS Calibur (Becton Dickin-
son) using Cell Quest Software. The surface area of PanD24 and GBM cells was calculated from the projected diameter of
non-adherent cells obtained from phase contrast images.
Immunohistochemistry of the Brain
For immunohistochemistry of the tumor bearing brains, micewere sacrificed as described above and brains were extracted and fixed
in 4% PFA overnight. 100 mm coronal sections were prepared using a vibratome (Leica, Germany). Sections were stored in PBS with
0.05% sodium azide until staining. For the staining, sections were incubated in PBS with 0.3% Triton X-100 and 5% horse serum for
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one h to block unspecific binding sites. For different analyses, sections were stained with anti-phospho ERK (1:200; CST), anti-phos-
pho Ser 473 Akt (1:25; CST), anti-cleaved Caspase-3 (1:100; CST), anti-Ki67 (1:200; Novus) and anti-pH3 (1:1000; Millipore) antibody
diluted in blocking solution for 72 h at 4C with shaking. After washing the sections 3 times for 5 min each with PBS, secondary anti-
body staining was performed using the appropriate Alexa-fluorophore antibodies diluted in blocking buffer for 2 h at room temper-
ature. Furthermore, Hoechst33342was added to the secondary antibody dilution to stain for nuclei. Sections were thenwashed three
times for 5 min with PBS, and in a last step with PB (Phosphate buffer without salt) buffer. After mounting with Fluoromount-G, the
sections were allowed to dry at room temperature for overnight and were stored in the dark at 4C until imaging.
Sphere Formation Assay
Neurosphere assays were performed as previously described with slight modifications (Ferro´n et al., 2007). In brief, tumorspheres
were harvested 3 to 7 days after culturing by centrifugation and dissociated using Accutase (ThermoFisher), thereafter cells were
centrifuged and Accutase was replaced by normal Neurobasal medium. The cell suspension was counted and 2 3 105 cells per
well were cultured on a 6 well plate. The next day, the newly formed spheres were collected by centrifugation, resuspended in
100 ml of Neurobasal medium and were incubated for 4 h with either the ligand coated membrane or the control DOPC membrane.
Afterward the cells were harvested and centrifuged, and the cell pellet was shortly treated with Accutase to obtain a single cell sus-
pension. For the sphere formation assay 500 cells/well were seeded in a 96 well plate. From each condition 10 wells were plated and
analyzed. The number of tumorspheres per well was scored by microscopic examination 10 days after seeding.
Endothelial Tube Formation Assay
HUVECs (Lonza) were maintained in endothelial basal medium-2 (EBM-2, Lonza) supplemented with EGM-2 SingleQuot Kit Supple-
ments and Growth Factors (Lonza) on 0.1% gelatin-coated flasks. The endothelial tube formation assay was performed according to
Arnaoutova et al., (2009). 80 ml of growth factor reduced matrigel was plated in each well of a 96-well plate and allowed to gel at 37C
for 30 min. 15000 HUVECS in EBM-2 supplemented with 35 ng/ml bFGF were seeded per well and the formation of endothelial tubes
was assessed after 12 hours. For visualization, tubes were stained with the live cell dye Calcein AM (8 mg/ml) before imaging. Exper-
iments were performed in triplicates.
For CD95L stimulation, HUVECs were stimulated for 4 hours on control- or mCD95L- supported membranes prior to plating on
matrigel.
Soluble ICAM1 Binding Assay
Culture of mouse bone marrow-derived neutrophils and soluble ICAM1 binding assay was performed as previously described (Gao
et al., 2016). Neutrophils were cultivated in RPMI (2% FCS) for 4 hours before stimulation. Subsequently, the cells were suspended in
Hanks Balanced Salt Solution containing 1mMCaCl2 andMgCl2. Next, the cell suspension was stimulated onmCD95Lmembranes
or on DOPCmembranes in the presence of ICAM1/FC (20mg/ml, R&D systems, USA) and PE-conjugated anti-human IgG1 (Fc-spe-
cific; Southern Biotechnology, USA) for 10 min at 37C. Anti-CD11b (10 mg/ml) antibody was used to block the Mac-1-dependent
ICAM1 binding. The binding of ICAM1 was determined by flow cytometry.
pTyr-Western Blot Analysis of Single Cells and Spheres
GBM cells were dissociated by Accutase treatment for 4 min one day before the experiment and plated as 53 105 cells per well into
6-well plate. Next day, cells in one well was dissociated by Accutase and plated into 10 cm plate for 1 h recovery. Thereafter, the cells
in the 10 cm plate were used as single cell sample and the cells taken from 6-well plate were used as sphere sample. The samples
were then collected and lysed for western blot analysis against generic pTyr (4G10, Millipore) antibody.
Inflow Microscopy
GBM cells were dissociated by Accutase treatment for 4 min and 53 105 cells were plated into 10 cm plate for 3 h. For pTyr control
samples, cells were either treated with EGF (100 ng/ml, 10 min) or vanadate (1 mM, 30 min) after cell dissociation and plating for 3 h.
Thereafter, the cells were collected and fixedwith paraformaldehyde (1.5%) for 10min at RT. Consequently, cells were permeabilized
with saponin (0.1%) for 20min and stainedwith the following antibody and fluorescent dyemixture in blocking buffer (1%BSA in PBS)
for 30 min; DAPI (Sigma; 1:10000), pTyr-PE (4G10, Millipore; 1:15), Phalloidin-Alexa fluorophore 488 (Thermo Fischer; 1:800). There-
after, cells were washed and resuspended in PBS. Finally, samples were subjected to Inflow microscopy (ImageStreamX) and
10,000-20,000 cells per sample were acquired using 60 x objective.
Analysis of phalloidin and pTyr signal intensities in singlets versus doublets was performed using IDEAS 6.0 software. Briefly, cells
that were out of focus were gated out using the ‘‘Gradient RMS’’ feature. Next, singlets and potential doublets were gated using area
(Area_M07) and intensity (Intensity_MC_Ch7) features based on the nuclei staining. After that, the real doublets were further gated
using the ‘‘Aspect Ratio Intensity_M01_Ch01’’ and ‘‘Area_M01’’ features. Aspect ratio is theminor axis intensity divided bymajor axis
intensity based on the brightfield intensity of the samples. In the final step, mean pixel intensity and mean fluorescent intensity
(total intensity) of the respective signals were automatically calculated in the singlet and doublet populations.
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Phosphotyrosine Immunoprecipitation and LC-MS/MS Analysis
Themagnetic beads conjugated with anti-phosphotyrosine (Millipore) were used to immunoprecipitate (IP) tyrosine phosphoproteins
from GBM6 CD95 wild-type (CD95wt) or GBM6 CD95 Alanine mutant (CD95Ala) cells that were stimulated with Apo-1 (Apogenix) for
5 min prior to IP. Briefly, 1 mg of cell lysate was incubated with magnetic beads overnight at 4C by rotation. Beads were washed
extensively in lysis buffer (Pierce IP lysis buffer) with inhibitors (cOmplete protease inhibitor cocktail, vanadate and phosphatase in-
hibitor cocktail) and boiled to elute enriched tyrosine phosphoproteins from beads. The IP samples and flow-through (FT) were sub-
jected to MS/MS analysis. After Coomassie staining, region of interest corresponding to the size of CD95 (40 - 50 kDa) were excised
from gel and subjected to in-gel digestion with trypsin. Samples were analyzed by LC-MS/MS using nanoflow-HPLC system inter-
faced to electrospray Q-TOF tandem mass spectrometers. Protein identification via peptide MS/MS spectra was achieved by using
the Mascot software for searching the NCBI non-redundant protein database.
QUANTIFICATION AND STATISTICAL ANALYSIS
The statistical data reported in this study include results from at least three biological replicates, except for MS analysis. All statistical
analyses were performed in GraphPad Prism Version 5 (GraphPad Software) and expressed as mean ± standard error of the mean
(SEM). Statistical significance was determined using one-way ANOVA for multiple comparisons, or two-tailed paired Student’s t test
when applied to two independent groups, * p < 0.05, ** p < 0.01, and *** p < 0.001.
Calculation of Intermolecular Distance hdi
The intermolecular distance hdi between the ligand molecules on the membrane surface was controlled by adjusting the fraction
cbiotin of the lipids functionalized with biotin anchors (DOPE-biotin). As we reported in previous accounts (Burk et al., 2015; Kaindl
et al., 2012), DOPE-biotin lipids are uniformly mixed with matrix lipids as monomers and thus the intermolecular distance between







Considering the extremely high affinity of biotin-neutravidin crosslinkers ðkD  1015 MÞ (Helm et al., 1991), quartz crystal microbal-
ance data demonstrated that the binding stoichiometry of biotin-DOPE and biotinylated protein is 1:1 afterz300 min (Burk, 2015).
The density r of CD95L on the membrane corresponds to:








The number of apoptotic cells over time followed a sigmoid curve, which was fittedwith a Hill-equation (solid lines) to characterize the
dynamics of the cellular response:
The Hill equation was used as an empirical indicator to judge the cooperativity of the reaction as a function of time t :







where cmax and cmin are the maximum and minimum level of the fraction of cells adherent to the surface c. thalf is the time after which
half of the apoptotic cells have died. Its value is reported in Tables S2 and S4 as ‘‘half-time.’’ The cooperativity coefficient (Hill co-
efficient) adopted values from1 to 6 indicating the necessity of neighboring CD95L to diffuse to the optimal confinement, before the
signal is transduced. In case of the optimal distance hdi; the cooperativity coefficient is the lowest, n z1, because the reaction
immediately takes place with no lag time. This is a quantitative indication that the pre-confinement of CD95L molecules has a major
impact on the reaction kinetics.
DATA AND CODE AVAILABILITY
The raw data supporting the current study are available from the Lead Contacts upon request. All software is commercially available.
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